Different patterns of mast cells distinguish diffuse from encapsulated neurofibromas in patients with neurofibromatosis 1

Journal of Histochemistry and Cytochemistry

Volumn 59, Issue 6, 2011, Pages 584-590

  Tucker, Tracy ^a   Riccardi, Vincent M ^b   Sutcliffe, Margaret ^c   Vielkind, Juergen ^c   Wechsler, Janine ^d   Wolkenstein, Pierre ^d   Friedman, Jan M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b The Neurofibromatosis Institute   (United States)

^c BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

Image analysis; Immunohistochemistry; Mast cells; Neurofibromas; Neurons; Nf1; Paraffin material

Indexed keywords

ARTICLE; CANCER PATIENT; CELL DENSITY; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE NEUROFIBROMA; ENCAPSULATED NEUROFIBROMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAST CELL; NEUROFIBROMA; NEUROFIBROMATOSIS; PERINEURIUM; PRIORITY JOURNAL; TISSUE TYPES; ANIMAL; IMMUNOHISTOCHEMISTRY; MOUSE; MOUSE MUTANT; PATHOLOGY;

ANIMALS; HUMANS; IMMUNOHISTOCHEMISTRY; MAST CELLS; MICE; MICE, KNOCKOUT; NEUROFIBROMA; NEUROFIBROMATOSIS 1;

EID: 79960901447     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155411407340     Document Type: Article

References (21)

1. Bienenstock J, MacQueen G, Sestini P, Marshall JS, Stead RH, Perdue MH. 1991. Mast cell/nerve interactions in vitro and in vivo. Am Rev Respir Dis. 143:S55-S58.
2. Bienenstock J, Tomioka M, Matsuda H, Stead RH, Quinonez G, Simon GT, Coughlin MD, Denburg JA. 1987. The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions. Int Arch Allergy Appl Immunol. 82:238-243.
3. Crowe F, Schull W, Neel J. 1956. Multiple neurofibromatosis. Springfield, IL: Charles C Thomas.
4. Friedman JM. 1999. Epidemiology of neurofibromatosis type 1. Am J Med Genet. 89:1-6.
5. Friedman JM, Riccardi VM. 1999. Clinical and epidemiological features. In Gutmann DH, MacCollin M, Riccardi VM, eds. Neurofibromatosis: phenotype, natural history, and pathogenesis. Baltimore: John Hopkins University Press. p. 26-86.
6. Giorno R, Claman HN. 1988. Mast cells and neurofibromatosis. Neurofibromatosis. 1:100-104.
7. Giorno R, Lieber J, Claman HN. 1989. Ultrastructural evidence for mast cell activation in a case of neurofibromatosis. Neurofibromatosis. 2:35-41.
8. Harkin J, Reed R. 1968. Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology. Isaacson P. 1976. Mast cells in benign nerve sheath tumours. J Pathol. 119:193-196.
9. Johnson MD, Kamso-Pratt J, Federspiel CF, Whetsell WO Jr. 1989. Mast cell and lymphoreticular infiltrates in neurofibromas: comparison with nerve sheath tumors. Arch Pathol Lab Med. 113:1263-1270.
10. Korf B, Rubenstein A. 2005. Neurofibromatosis: a handbook for patients, families and health care professionals. 2nd ed. New York: Thieme Medical.
11. Masson P. 1970. Human tumors: histology, diagnosis and technique. 2nd ed. Detroit, MI: Wayne State University Press.
12. National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. 1988. Neurofibromatosis. 1:172-178.
13. Riccardi VM. 1981. Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells. Birth Defects Orig Artic Ser. 17:129-147.
14. Riccardi VM. 1987. Mast-cell stabilization to decrease neurofibroma growth: preliminary experience with ketotifen. Arch Dermatol. 123:1011-1016.
15. Riccardi VM. 1992. An overview of NF-1: dysplasia and neoplasia. In Riccardi VM, ed. Neurofibromatosis: phenotype, natural history and pathogenesis. Baltimore: Johns Hopkins University Press. p. 18-39.
16. Riccardi VM. 1993. A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching. Arch Dermatol. 129:577-581.
17. Riccardi VM, Wald JS. 1987. Discounting an adverse maternal effect on severity of neurofibromatosis. Pediatrics. 79:386-393.
18. Wheater P, Burkitt H, Daniels V. 1993. Functional histology: a text and colour atlas. New York: Churchill Livingstone. Wiesteler O, Radner H. 1994. Pathology of neurofibromatosis 1 and 2. In Huson S, Hughes R, eds. The neurofibromatoses: a pathogenetic and clinical overview. London: Chapman & Hall Medical. p. 135-159.
19. Woodruff JM. 1999. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Genet. 89:23-30.
20. Yang FC, Ingram DA, Chen S, Zhu Y, Yuan J, Li X, Yang X, Knowles S, Horn W, Li Y, et al. 2008. Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kitdependent bone marrow. Cell. 135:437-448.
21. Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF. 2002. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science. 296:920-922.